341 related articles for article (PubMed ID: 8794442)
1. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
Saure A; Hirvonen E; Milsom I; Christensen A; Damber MG
Maturitas; 1996 May; 24(1-2):111-8. PubMed ID: 8794442
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
Saure A; Planellas J; Poulsen HK; Jaszczak P
Maturitas; 2000 Feb; 34(2):133-42. PubMed ID: 10714908
[TBL] [Abstract][Full Text] [Related]
3. Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
Marslew U; Munk-Nielsen N; Nilas L; Riis BJ; Christiansen C
Maturitas; 1994 Oct; 19(3):225-37. PubMed ID: 7799829
[TBL] [Abstract][Full Text] [Related]
4. A comparative 2-year study of the effects of sequential regimens of 1 mg 17beta-estradiol and trimegestone with a regimen containing estradiol valerate and norethisterone on the bleeding profile and endometrial safety in postmenopausal women.
Koninckx PR; Spielmann D
Gynecol Endocrinol; 2005 Aug; 21(2):82-9. PubMed ID: 16294460
[TBL] [Abstract][Full Text] [Related]
5. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
Baerug U; Winge T; Nordland G; Faber-Swensson E; Heldaas K; Norling B; Larsen S; Arce JC
Climacteric; 1998 Sep; 1(3):219-28. PubMed ID: 11907946
[TBL] [Abstract][Full Text] [Related]
6. Efficacy on climacteric symptoms of a continuous combined regimen of 1 mg 17beta-estradiol and trimegestone versus two regimens combining 1 or 2 mg 17beta-estradiol and norethisterone acetate.
Gambacciani M; Spielmann D; Genazzani AR
Gynecol Endocrinol; 2005 Aug; 21(2):65-73. PubMed ID: 16294457
[TBL] [Abstract][Full Text] [Related]
7. Endometrial safety and tolerability of triphasic sequential hormone replacement estradiol valerate/medroxyprogesterone acetate therapy regimen.
Rees MC; Kuhl H; Engelstein M; Mattila L; Mäenpää J; Mustonen M;
Climacteric; 2004 Mar; 7(1):23-32. PubMed ID: 15259280
[TBL] [Abstract][Full Text] [Related]
8. A two-year double-blind controlled study of the clinical effect of combined and sequential postmenopausal replacement therapy and steroid metabolism during treatment.
Obel EB; Munk-Jensen N; Svenstrup B; Bennett P; Micic S; Henrik-Nielsen R; Nielsen SP; Gydesen H; Jensen BM
Maturitas; 1993 Jan; 16(1):13-21. PubMed ID: 8429800
[TBL] [Abstract][Full Text] [Related]
9. Bleeding patterns in peri and postmenopausal women taking a continuous combined regimen of estradiol with norethisterone acetate or a conventional sequential regimen of conjugated equine estrogens with medrogestone.
von Holst T; Lang E; Winkler U; Keil D
Maturitas; 2002 Dec; 43(4):265-75. PubMed ID: 12468135
[TBL] [Abstract][Full Text] [Related]
10. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology.
Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J
Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325
[TBL] [Abstract][Full Text] [Related]
11. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
12. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
Johannisson E; Holinka CF; Arrenbrecht S
Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
[TBL] [Abstract][Full Text] [Related]
13. Bleeding profile and endometrial safety of continuous combined regimens 1 mg 17beta-estradiol/trimegestone versus 1 or 2 mg 17beta-estradiol/norethisterone acetate in postmenopausal women.
Bouchard P; De Cicco-Nardone F; Spielmann D; Garcea N;
Gynecol Endocrinol; 2005 Sep; 21(3):142-8. PubMed ID: 16353319
[TBL] [Abstract][Full Text] [Related]
14. A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1 mg 17beta-estradiol and trimegestone compared with a regimen containing 1 mg estradiol valerate and norethisterone over a two-year period.
Pornel B; Spielmann D
Gynecol Endocrinol; 2005 Aug; 21(2):74-81. PubMed ID: 16294458
[TBL] [Abstract][Full Text] [Related]
15. Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study.
Samsioe G; Boschitsch E; Concin H; De Geyter C; Ehrenborg A; Heikkinen J; Hobson R; Arguinzoniz M; Ibarra de Palacios P; Scheurer C; Schmidt G;
Climacteric; 2006 Oct; 9(5):368-79. PubMed ID: 17080587
[TBL] [Abstract][Full Text] [Related]
16. Continuous versus cyclical transdermal estrogen replacement therapy in postmenopausal women: influence on climacteric symptoms, body weight and bleeding pattern.
Lübbert H; Nauert C
Maturitas; 1997 Dec; 28(2):117-25. PubMed ID: 9522319
[TBL] [Abstract][Full Text] [Related]
17. Impact on uterine bleeding and endometrial thickness: tibolone compared with continuous combined estradiol and norethisterone acetate replacement therapy.
Dören M; Rübig A; Coelingh Bennink HJ; Holzgreve W
Menopause; 1999; 6(4):299-306. PubMed ID: 10614676
[TBL] [Abstract][Full Text] [Related]
18. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
Samsioe G; Dvorak V; Genazzani AR; Hamann B; Heikkinen J; Mueck AO; Suzin J; Kawakami FT; Ferreira A; Sun D; Arguinzoniz M
Maturitas; 2007 Jun; 57(2):171-81. PubMed ID: 17317046
[TBL] [Abstract][Full Text] [Related]
19. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
al-Azzawi F; Wahab M; Thompson J; Pornel B; Hirvonen E; Ylikorkala O; van der Mooren MJ; Dillon J; Magaril C
Climacteric; 2001 Dec; 4(4):343-54. PubMed ID: 11770191
[TBL] [Abstract][Full Text] [Related]
20. Effective bleeding control and symptom relief by lower dose regimens of continuous combined hormone replacement therapy: a randomized comparative dose-ranging study.
Bruhat M; Rudolf K; Vaheri R; Kainulainen P; Timonen U; Viitanen A
Maturitas; 2001 Dec; 40(3):259-71. PubMed ID: 11731187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
